RxDoctor Payments Data

Jennifer Sartori, DPM

Podiatrist · Portsmouth, NHNPI 1316932361

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $471 of the $649 with a category attached, or 72.5%. 11 manufacturers reported payments, led by Stryker at 55.8% of the total. Reporting peaked in 2019 at $322 and has fallen 87.8% since, to $39 in 2024.

$649in general payments, 2019–2025

Across 19 payments — averaging $34.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$362
  • Dynasplint Systems Inc.$45
  • Paragon 28, Inc.$41
  • Orthofix Medical, Inc.$36
  • Bioventus LLC$35
  • Smith+Nephew$28
  • plus $103 from 5 others

What the payments were for

  • Food & beverage$47173%
  • Gifts$17827%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)6$362
Dynasplint Systems Inc.1$45
Paragon 28, Inc.1$41
Orthofix Medical, Inc.2$36
Bioventus LLC2$35
Smith+Nephew2$28
Kerecis Limited1$26
Mimedx Group, Inc.1$23
Medela LLC1$19
Integra Lifesciences Corporation1$19
Kairos Surgical Inc1$16

How this compares

Too few podiatrist providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$120,941
Medicare patients
390
Services billed
1,690

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin12$258
Methylprednisolone12$115
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$68

Paid to pharmacies, not to this prescriber.

Other podiatrist in Portsmouth

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →